To accommodate increased demand for cold-chain storage, MNX Global Logistics opened a dedicated logistics facility in Amsterdam, just outside of Amsterdam Airport Schiphol. The building has validated temperature-controlled storage capabilities and will serve as the operations and warehousing hub for MNX’s Life Sciences and Medical Device customers throughout Europe.
MNX CEO and president Paul J. Martins said his company has seen “double-digit growth” in demand for the shipment of biologics and medical devices in Europe, the Middle East and Africa (EMEA) over the past 12 months, thus necessitating the added cold-chain capacity.
The new facility’s capacity exceeds 14,000 square feet, with the option to expand by an additional 18,000 square feet. The HACCP (Hazard Analysis and Critical Control Point) and GDP-compliant structure was designed to exceed current standards for handling biopharmaceutical, radiopharmaceutical and medical device shipments, the company said.
The cold-chain center features -20°C, 2-8°C and 18°C temperature-controlled storage areas with 24/7 monitoring, back-up systems and security in order to ensure the integrity and security of temperature sensitive and high value shipments. The center also allows for cross docking, inventory storage and transportation for clients needing temperature-sensitive control, said Jan Willem van‘t Riet, MNX Senior Vice President for EMEA.Like This Post